References
- Kardon N B, Slepowitz G, Kochen J A. Childhood acute lymphoblastic leukemia associated with an unusual 8;14 translocation. Cancer Genet Cytogenet 1982; 6: 339–343
- Murphy S B, Bowman W P, Abromowitch M, Mirro J, Ochs J, Rivera G, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732–1739
- Moore S, Suttle J, Bain S, Story C, Rice M. Acute lymphoblastic leukemia characterized by t(8;14)(q11.2;q32). Cancer Genet Cytogenet 2003; 141: 1–4
- Quilichini B, Zattara H, Casalonga F, Bastide-Alliez L A, Curtillet C, Fossat C, et al. A new case of t(8;14)(q11;q32) in an acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol. 2003, Available at: http://AtlasGeneticsOncology.org/Reports/814QuilichiniID100007.html Last accessed 20 October 2008
- Balicek P, Abasova J, Hak J. A case of Down syndrome with acute lymphoblastic leukemia and t(8;14)(q11;q32). Atlas Genet Cytogenet Oncol Haematol. 2001, Available at: http://AtlasGeneticsOncology.org/Reports/t814BalicekID100002.html Last accessed 20 October 2008
- Akasaka T, Balasas T, Russell L J, Sugimoto K J, Majid A, Walewska R, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 2007; 109: 3451–3461
- Kerndrup G B, Rosthøj S. A case of pre-B ALL with t(8;14)(q11;q32). Atlas Genet Cytogenet Oncol Haematol. 2001, Available at: http://AtlasGeneticsOncology.org/Reports/t814KerndrupID100001.html. Last accessed 20 October 2008
- Kaleem Z, Shuster J J, Carroll A J, Borowitz M J, Pullen D J, Camitta B M, et al. Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia 2000; 14: 238–240
- Secker-Walker L M, Hawkins J M, Prentice H G, Mackie P H, Heerema N A, Provisor A J. Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet 1993; 70: 148–150
- Bruning R D, Matutes E, Flandrin G, Vardiman J. Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, L H Nancy, S Harald, W V James. IARC, Lyon 2001; 89–91
- Shivakumar R, Tan W, Wilding G E, Wang E S, Wetzler M. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia – a review of 101 cases. Ann Oncol 2008; 19: 1634–1638
- Tenen D G. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3: 89–101
- Helbling D, Mueller B U, Timchenko N A, Hagemeijer A, Jotterand M, Meyer-Monard S, et al. The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc Natl Acad Sci USA 2004; 101: 13312–13317